ISDA

Entry Detail

PDB ID:

2F9U

Keywords:

VIRAL PROTEIN

Title:

HCV NS3 protease domain with NS4a peptide and a ketoamide inhibitor with a P2 norborane

Biological Source:

Source Organism:

Hepatitis C virus,

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2005-12-06

Release Date:

2006-06-06

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.60 Å

R-Value Free:

0.28

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

H 3 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:NS3 protease/helicase'
Chain IDs:A, C
Chain Length:199
Number of Molecules:2
Biological Source:Hepatitis C virus

UniProt ID:Q91RS4 Pfam ID:PF02907

Polymer Type:polypeptide(L)
Description:polyprotein
Chain IDs:B, D
Chain Length:23
Number of Molecules:2
Biological Source:

Ligand Molecules

5NH

Primary Citation

Novel Inhibitors of Hepatitis C NS3-NS4A Serine Protease Derived from 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid.

Venkatraman, S, Njoroge, F.G, Wu, W, Girijavallabhan, V, Prongay, A.J, Butkiewicz, N, Pichardo, J, Kim, J.L, Morgenstern, K.A, Lin, C, Fox, T, Dwyer, M.D, Landro, J.A, Chambers, S.P, Markland, W, Lepre, C.A, O'Malley, E.T, Harbeson, S.L, Rice, C.M, Murcko, M.A, Caron, P.R, Thomson, J.A, Bogen, S, Saksena, A.K, Arasappan, A, Gu, N, Njoroge, F.G, Girijavallabhan, V, Pichardo, J, Butkiewicz, N, Prongay, A, Madison, A, Venkatraman, S, Njoroge, F.G, Girijavallabhan, V.M, Madison, V.S, Yao, N.H, Prongay, A.J, Butkiewicz, N, Pichardo, J, Chen, K.X, Njoroge, F.G, Vibulbhan, B, Prongay, A, Pichardo, J, Madison, V, Buevich, A, Chan, T.M, Arasappan, A, Njoroge, F.G, Parekh, T.N, Yang, X, Pichardo, J, Butkiewicz, N, Prongay, A, Yao, N, Girijavallabhan, V.Show

Bioorg.Med.Chem.Lett. 16 1628 1632 (2006)

PMID: 16413182 DOI: 10.1016/j.bmcl.2005.12.046

Abstact

Prolonged hepatitis C infection is the leading cause for cirrhosis of the liver and hepatocellular carcinoma. The etiological agent HCV virus codes a single polyprotein of approximately 3000 amino acids that is processed with the help of a serine protease NS3A to produce structural and non-structural proteins required for viral replication. Inhibition of NS3 protease can potentially be used to develop drugs for treatment of HCV infections. Herein, we report the development of a series of novel NS3 serine protease inhibitors derived from 2-aza-bicyclo[2.2.1]-heptane carboxylic acid with potential therapeutic use for treatment of HCV infections.

Legend

Protein

Chemical

Disease

Primary Citation of related structures